Piper Jaffray Upgrades NovaMed (NOVA) to Neutral

Piper Jaffray upgraded NovaMed (NASDAQ: NOVA) from Underweight to Neutral. PT increased from $8.75 to $13.25.

For more ratings news on NovaMed click here and for the rating history of NovaMed click here.

Shares of NovaMed closed at $13.19 yesterday, with a 52 week range of $3.04-$13.31.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
• Macquarie Upgrades SBA Communications (SBAC) to Outperform
• Deutsche Bank Upgrades Siemens (SI) to Buy; Subtle Shift

Create E-mail Alert Related Categories

Upgrades

Related Entities

Piper Jaffray

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter